I am too poor/tight to pay for the subscription but if accurate (I am sure your re-telling is) that's infuriating!
We need positive coverage that promotes the blue-sky value here and we need to get our story out accurately so people can see that. We don't get many front-page media opportunities and need to make them count.
I find with a company like ours, 2nd, 3rd and 4th order thinking is required to see where this could go if the stars align and how that manifests in a real appreciation of the actual value. That won't happen if reporting on our potential can't even accurately relay our financial position - which is a concern given the nature of the masthead.
A real shame!
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.54%
!
$12.92

I am too poor/tight to pay for the subscription but if accurate...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.92 |
Change
0.070(0.54%) |
Mkt cap ! $1.607B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.85 | $8.049M | 616.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | $12.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | 12.910 |
4 | 4488 | 12.900 |
2 | 1762 | 12.890 |
2 | 3348 | 12.880 |
1 | 1508 | 12.850 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 100 | 1 |
13.040 | 6060 | 2 |
13.050 | 1508 | 1 |
13.060 | 7205 | 8 |
13.080 | 1508 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online